The Association of Anticoagulation Intensity with Outcomes in Hospitalized COVID-19 Patients

<div>Stratification of risk of thrombosis in COVID-19 patients. (a) Definition of low-, intermediate- and high-risk patients infected with COVID-19. (b) Anticoagulation regimen used in standard-dose prophylaxis, high-dose prophylaxis, and therapeutic anticoagulation groups, with the number of patients per group.</div>

Advances in Hematology

fig1

Figure 1

Figure 1: The Association of Anticoagulation Intensity with Outcomes in Hospitalized COVID-19 Patients 